Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial

R Saraceno; L Andreassi; F Ayala; Bongiorno; A Giannetti; P Lisi; P Martini; Ketty Peris; A Peserico; S. Chimenti

doi:10.1080/09546630701646156

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial

R Saraceno
, L Andreassi
, F Ayala
, Bongiorno
, A Giannetti
, P Lisi
, P Martini
, Ketty Peris
, A Peserico
, S. Chimenti

Research output: Contribution to journal › Article

36 Citations (Scopus)

Abstract

A clinical trial was performed to evaluate the efficacy, speed of response, side effects and quality of life of patients treated with calcipotriol/betamethasone dipropionate (Dovobet) for 4 weeks followed by maintenance with calcipotriol for 8 weeks (group A) versus calcipotriol (Daivonex) alone for 12 weeks (group B) for the treatment of psoriasis.

Original language	English
Pages (from-to)	361-365
Number of pages	5
Journal	THE JOURNAL OF DERMATOLOGICAL TREATMENT
Volume	18
DOIs	https://doi.org/10.1080/09546630701646156
Publication status	Published - 2007

Keywords

Administration, Cutaneous
Adolescent
Adult
Aged
Aged, 80 and over
Analysis of Variance
Betamethasone
Calcitriol
Dermatologic Agents
Drug Administration Schedule
Drug Combinations
Female
Humans
Male
Middle Aged
Psoriasis
Quality of Life
Severity of Illness Index
Treatment Outcome

Access to Document

10.1080/09546630701646156

Cite this

Saraceno, R., Andreassi, L., Ayala, F., Bongiorno, Giannetti, A., Lisi, P., Martini, P., Peris, K., Peserico, A., & Chimenti, S. (2007). Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. THE JOURNAL OF DERMATOLOGICAL TREATMENT, 18, 361-365. https://doi.org/10.1080/09546630701646156

@article{cac88e1f31d64ec7a3652525416b3f10,

title = "Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial",

abstract = "A clinical trial was performed to evaluate the efficacy, speed of response, side effects and quality of life of patients treated with calcipotriol/betamethasone dipropionate (Dovobet) for 4 weeks followed by maintenance with calcipotriol for 8 weeks (group A) versus calcipotriol (Daivonex) alone for 12 weeks (group B) for the treatment of psoriasis.",

keywords = "Administration, Cutaneous, Adolescent, Adult, Aged, Aged, 80 and over, Analysis of Variance, Betamethasone, Calcitriol, Dermatologic Agents, Drug Administration Schedule, Drug Combinations, Female, Humans, Male, Middle Aged, Psoriasis, Quality of Life, Severity of Illness Index, Treatment Outcome, Administration, Cutaneous, Adolescent, Adult, Aged, Aged, 80 and over, Analysis of Variance, Betamethasone, Calcitriol, Dermatologic Agents, Drug Administration Schedule, Drug Combinations, Female, Humans, Male, Middle Aged, Psoriasis, Quality of Life, Severity of Illness Index, Treatment Outcome",

author = "R Saraceno and L Andreassi and F Ayala and Bongiorno and A Giannetti and P Lisi and P Martini and Ketty Peris and A Peserico and S. Chimenti",

year = "2007",

doi = "10.1080/09546630701646156",

language = "English",

volume = "18",

pages = "361--365",

journal = "THE JOURNAL OF DERMATOLOGICAL TREATMENT",

issn = "0954-6634",

publisher = "Martin Dunitz Limited:The Livery House, 7-9 Pratt Street, London NW1 0AE United Kingdom:011 44 20 74822202, INTERNET: http://www.dunitz.co.uk, Fax: 011 44 20 72670159",

}

Saraceno, R, Andreassi, L, Ayala, F, Bongiorno, Giannetti, A, Lisi, P, Martini, P, Peris, K, Peserico, A & Chimenti, S 2007, 'Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial', THE JOURNAL OF DERMATOLOGICAL TREATMENT, vol. 18, pp. 361-365. https://doi.org/10.1080/09546630701646156

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. / Saraceno, R; Andreassi, L; Ayala, F et al.
In: THE JOURNAL OF DERMATOLOGICAL TREATMENT, Vol. 18, 2007, p. 361-365.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial

AU - Saraceno, R

AU - Andreassi, L

AU - Ayala, F

AU - Bongiorno,

AU - Giannetti, A

AU - Lisi, P

AU - Martini, P

AU - Peris, Ketty

AU - Peserico, A

AU - Chimenti, S.

PY - 2007

Y1 - 2007

N2 - A clinical trial was performed to evaluate the efficacy, speed of response, side effects and quality of life of patients treated with calcipotriol/betamethasone dipropionate (Dovobet) for 4 weeks followed by maintenance with calcipotriol for 8 weeks (group A) versus calcipotriol (Daivonex) alone for 12 weeks (group B) for the treatment of psoriasis.

AB - A clinical trial was performed to evaluate the efficacy, speed of response, side effects and quality of life of patients treated with calcipotriol/betamethasone dipropionate (Dovobet) for 4 weeks followed by maintenance with calcipotriol for 8 weeks (group A) versus calcipotriol (Daivonex) alone for 12 weeks (group B) for the treatment of psoriasis.

KW - Administration, Cutaneous

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Analysis of Variance

KW - Betamethasone

KW - Calcitriol

KW - Dermatologic Agents

KW - Drug Administration Schedule

KW - Drug Combinations

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Psoriasis

KW - Quality of Life

KW - Severity of Illness Index

KW - Treatment Outcome

KW - Administration, Cutaneous

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Analysis of Variance

KW - Betamethasone

KW - Calcitriol

KW - Dermatologic Agents

KW - Drug Administration Schedule

KW - Drug Combinations

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Psoriasis

KW - Quality of Life

KW - Severity of Illness Index

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/57536

U2 - 10.1080/09546630701646156

DO - 10.1080/09546630701646156

M3 - Article

SN - 0954-6634

VL - 18

SP - 361

EP - 365

JO - THE JOURNAL OF DERMATOLOGICAL TREATMENT

JF - THE JOURNAL OF DERMATOLOGICAL TREATMENT

ER -

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this